Gastric Cancer Market Therapeutic Review
Cancer is a condition where an error or mutation in the cell’s DNA occurs, causing it to grow at a rapid rate. A cancer cell continues living while a normal cell would die, thus, accumulating to form a tumor that can break off and spread throughout the body.
Gastric cancer is when such a condition occurs in the stomach and has the tendency to grow through the wall of the stomach to invade nearby organs including lymph nodes and lymph vessels.
The causes of stomach cancer are rather unclear in medical study; however, there is a strong correlation between a diet high in smoked, salted and pickled foods, obesity and ageing. People with Helicobacter infections are also highly prone to gastric cancer.
Symptoms of gastric cancer may include, fatigue, feeling bloated after eating, severe heartburn and indigestion, stomach pain, persistent and unexplained vomiting and nausea, unintentional weight loss, belching, anemia, and persistent ulcer. Its medical diagnosis techniques involve upper endoscopy, imaging tests and exploratory surgery.
Treatment options include surgery, chemotherapy, radiotherapy and targeted therapy.
Global gastric cancer market is conspicuous by poor prognosis, because of the indolent nature of the disease. However, better diagnostic technology and shifting treatment market from chemotherapy to targeted therapies is expected to warrant positive growth in the years ahead.
Rising oncology drug spending, ageing population, increasing obese population and rising global male population are expected to drive this growth. Certain trends in the global gastric cancer market include, a healthy pipeline of combinations targeted therapies, shifting focus towards molecular targeted therapies, and keen interest in eradication H.
Pylori infection across the globe. The market is however, afflicted by certain challenges like low penetration of new targeted therapies and lack of reimbursement of cancer drugs.
The report provides an overview of the entire market through global and regional analysis. Prevalence and market value of gastric cancer across the globe and that of its various types and stages including advanced, her2 positive, stage III and metastatic gastric cancer have been analyzed.
Table of Content: Key Points
- Market Overview
1.4 Causes & Prevention
1.6 Treatment Options
- Global Market
2.1 Global Gastric Cancer Market by Prevalence
2.2 Global Advanced Gastric Cancer Market by Value
- Regional Markets
3.1. The U.S.
3.2 The European Union
3.3 The EU5
- Market Dynamics
4.1 Growth Drivers
4.1.1 Rising Spending on Targeted Cancer Therapies
4.1.2 Rising Oncology Drug Spending
4.1.3 Rising Ageing Population
4.1.4 Increasing Obese Population
4.1.5 Rising Global Male Population
4.1.6 Rising Cigarette Consumption
4.2.1 Combinations Targeted Therapies under Development
4.2.2 Targeted Agents in Development by Pathways
4.2.3 Shifting Focus towards Molecular Targeted Therapies
4.2.4 H. Pylori Eradication
4.3.1 Low Penetration of New Targeted Therapies
4.3.2 Lack of Reimbursement of Cancer Drugs
- Competitive Landscape
ACCESS REPORT at www.wiseguyreports.com/reports/161…port-2016-edition
Category: Market Research Publishers and RetailersCompany profile: Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs. Our Market Research Reports and Consulting Services ...
For more information: